|
1
|
Beisiegel U, Weber W, Ihrke G, et al: The
LDL-receptor related protein, LPR, is an apolipoprotein E-binding
protein. Nature. 341:162–170. 1989. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eichner JE, Dunn T, Perveen G, Thompson
DM, Stewart KE and Stroehla BC: Apolipoprotein E polymorphism and
cardiovascular disease: a HuGE review. Am J Epidemiol. 155:487–495.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mahley RW and Rall SC Jr: Apolipoprotein
E: Far more than a lipid transport protein. Annu Rev Genomics Hum
Gene. 1:507–537. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hartman RE, Laurer H, Longhi L, Bales KR,
Paul SM, McIntosh TK and Holtzman DM: Apolipoprotein E4 influences
amyloid deposition but not cell loss after traumatic brain injury
in a mouse model of Alzheimer’s disease. J Neurosci.
22:10083–10087. 2002.
|
|
5
|
Moysich KB, Freudenheim JL, Baker JA, et
al: Apolipoprotein E genetic polymorphism, serum lipoproteins, and
breast cancer risk. Mol Carcinog. 27:2–9. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zunarelli E, Nicoll JA, Migaldi M and
Trentini GP: Apolipoprotein E polymorphism and breast carcinoma:
correlation with cell proliferation indices and clinical outcome.
Breast Cancer Res Treat. 63:193–198. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Breslow JL: Genetic basis of lipoprotein
disorders. J Clin Invest. 84:373–380. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kervinen K, Södervik H, Mäkelä J, Lehtola
J, Niemi M, Kairaluoma MI and Kesäniemi YA: Is the development of
adenoma and carcinoma in proximal colon related to apolipoprotein E
genotype? Gastroenerology. 110:1785–1790. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kuusisto J, Koivisto K, Kervinen K, et al:
Association of apolipoprotein phenotypes with late onset
Alzheimer’s disease: population based study. BMJ. 309:636–638.
1994.
|
|
10
|
Cave WT Jr: Dietary fat effects on animal
models of breast cancer. Diet and Breast Cancer. Weisburger EK:
Plenum Press; New York: pp. 47–58. 1994, View Article : Google Scholar
|
|
11
|
Caroll KK, Braden LM, Bell JM and
Kalamegham R: Fat and cancer. Cancer. 58:1818–1825. 1986.
View Article : Google Scholar
|
|
12
|
Dunn JE: Breast cancer among American
Japanese in the San Francisco bay area. Natl Canc Inst Monogr.
47:157–160. 1977.PubMed/NCBI
|
|
13
|
Willett WC, Hunter DJ, Stampfer MJ, et al:
Dietary fat and fiber in relation to risk of breast cancer. An
8-year follow up. JAMA. 268:2037–2044. 1992.PubMed/NCBI
|
|
14
|
Goodwin PJ and Boyd NF: Critical appraisal
of the evidence that dietary fat intake is related to breast cancer
in humans. J Natl Cancer Inst. 79:473–485. 1987.PubMed/NCBI
|
|
15
|
Bingham SA, Gill C, Welch A, et al:
Comparison of dietary assessment methods in nutritional
epidemiology: weighted records v. 24 h recalls, food-frequency
questionnaries and estimated-diet records. Br J Nut. 72:619–643.
1994. View Article : Google Scholar
|
|
16
|
Törnberg SA, Holm LE and Carstensen JM:
Breast cancer risk in relation to serum cholesterol, serum
beta-lipoprotein, height, weight, and blood pressure. Acta Oncol.
27:31–37. 1988.PubMed/NCBI
|
|
17
|
Vatten LJ and Foss OP: Total serum
cholesterol and triglycerides and risk of breast cancer: a
prospective study of 24,329 Norwegian women. Cancer Res.
50:2341–2346. 1990.PubMed/NCBI
|
|
18
|
Gerber M, Cavallo F, Marubini E, et al:
Liposoluble vitamins and lipid parameters in breast cancer. A joint
study in northern Italy and southern France. Int J Cancer.
42:489–494. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vatten LJ, Foss OP and Kvinnsland S:
Overall survival of breast cancer patients in relation to
preclinically determined total serum cholesterol, body mass index,
height and cigarette smoking: a population-based study. Eur J
Cancer. 27:641–646. 1991. View Article : Google Scholar
|
|
20
|
Høyer AP and Engholm G: Serum lipids and
breast cancer risk: a cohort study of 5,207 Danish women. Cancer
Causes Control. 3:403–480. 1992.PubMed/NCBI
|
|
21
|
Kökoğlu E, Karaarslan I, Karaarslan HM and
Baloglu H: Alterations of serum lipids and lipoproteins in breast
cancer. Cancer Lett. 82:175–178. 1994.PubMed/NCBI
|
|
22
|
Giacomazzi J, Aguiar E, Palmero EI, et al:
Breast cancer screening in 10.000 women of an underserved
population in South Brazil: The NMAMAPOA cohort. J Clin Oncol.
23:1020–1027. 2005.
|
|
23
|
Caleffi M, Ribeiro RA, Duarte Filho DL, et
al: A model to optimize public health care and downstage breast
cancer in limited-resource populations in southern Brazil. Porto
Alegre Breast Health Intervention Cohort. BMC Public Health.
9:832009.PubMed/NCBI
|
|
24
|
Chang SJ, Hou MF, Tsai SM, Kao JT, Wu SH,
Hou LA and Tsai LY: Association between the apolipoprotein E
genotypes and breast cancer patients in Taiwanese. Breast Cancer
Res Treat. 98:109–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sposito AC, Caramelli B, Fonseca FA, et
al; Brazilian Society of Cardiology. IV Brazilian guideline for
dyslipidemia and atherosclerosis prevention: Department of
Atherosclerosis of Brazilian Society of Cardiology. Arq Bras
Cardiol. 88:2–19. 2007.(In Portuguese).
|
|
26
|
Hixson JE and Vernier DT: Restriction
isotyping of human apolipoprotein E by gene amplification and
cleavage with Hha I. J Lipid Res. 31:545–548.
1990.PubMed/NCBI
|
|
27
|
Howard BV, Gidding SS and Liu K:
Association of apolipoprotein E phenotype with plasma lipoproteins
in African-American and white young adults. The CARDIA Study
Coronary Artery Risk Development in Young Adults. Am J Epidemiol.
48:859–868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niemi M, Kervinen K, Kiviniemi H, et al:
Apolipoprotein E phenotype, cholesterol and breast and prostate
cancer. J Epidemiol Community Health. 54:938–939. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ojopi EPB, Bertoncini AB and Dias Neto E:
Apolipoproteína E e a doença de Alzheimer. Rev Psiq Clí. 31:26–33.
2004.
|
|
30
|
Chang NW, Chen DR, Wu CT, Aouizerat BE,
Chen FN, Hung SJ, Wang SH, Wei MF and Chang CS: Influences of
apolipoprotein E polymorphism on the risk for breast cancer and
HER2/neu status in Taiwan. Breast Cancer Res Treat. 90:257–261.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brandão AC, Pinheiro SP Jr, Pinhel MA, et
al: Polimorfismo genético da apolipoproteína E na doença arterial
periférica. J Vasc Br. 3:317–322. 2004.PubMed/NCBI
|
|
32
|
Feng J, Xiang L, Wan G, et al: Is APOE E a
favorable factor for the longevity: an association study in Chinese
population. J Genet. 90:343–347. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schwanke CH, da Cruz IB, Leal NF, Scheibe
R, Moriguchi Y and Moriguchi EH: Analysis of the association
between apolipoprotein E polymorphism and cardiovascular risk
factors in an elderly population with longevity. Arq Bras Cardiol.
78:561–570. 2002.(In English, Portuguese).
|
|
34
|
Souza D, Campos BF, Arruda EF, Yamamoto
LJ, Trindade DM and Tognola WA: Influence of the polymorphism of
apolipoprotein E in cerebral vascular disease. Arq Neuropsiquiatr.
61:7–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McNamara JJ, Molot M, Dunn R, Burran EL
and Stremple JF: Lipid metabolism after trauma. Role in the
pathogenesis of fat embolism. J Thoracic Cardiovasc Surg.
63:968–972. 1972.PubMed/NCBI
|
|
36
|
Morales M, Santana N, Soria A, Soria A,
Mosquera A, Ordovás J, Nóvoa J, Betancor P, Valerón PF, Díaz-Chico
B and Chirino R: Effects of tamoxifen on serum lipid and
apolipoprotein levels in postmenopausal patients with breast
cancer. Breast Cancer Res Treat. 49:265–270. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Instituto Nacional de Câncer José Alencar
Gomes da Silva. Coordenação de Prevenção e Vigilância Estimativa
2014. Incidência de Câncer no Brasil/Instituto Nacional de Câncer
José Alencar Gomes da Silva Coordenação de Prevenção e Vigilância
Rio de Janeiro: INCA; pp. 922014
|
|
38
|
Fuchs FD: Systemic arterial hypertension.
Epidemiology and risk factors. Arq Bras Cardiol. 63:443–444.
1994.(In Portuguese).
|
|
39
|
Duncan BB, Schimidt MI, Polanczyk CA,
Hormrich CS, Rosa RS and Achutti AC: Risk factors for
non-communicable diseases in a metropolitan area in the south of
Brazil. Prevalence and simultaneity. Rev Saude Publica. 27:43–48.
1993.(In Portuguese).
|
|
40
|
Gus I, Fischmann A and Medina C:
Prevalência dos fatores de risco da doença arterial coronariana no
Estado do Rio Grande do Sul. Arq Bras Cardiol. 78:478–483. 2002.(In
Portuguese).
|
|
41
|
Davignon J, Gregg RE and Sing CF:
Apolipoprotein E polymorphism and atherosclerosis. Arterioscler
Thromb Vasc Biol. 8:1–21. 1988. View Article : Google Scholar
|
